A therapeutic potential was reported for some TCF7L2 variants, for example, intronic rs290487 influenced the efficacy of repaglinide, an oral hypoglycemic agent, in Chinese T2DM patients [24]. The gene discussed is TCF7L2; the disease is type 2 diabetes mellitus.